TMED vs XBI

ATMED

BXBI

Measures won3–1TMED wins · of 6 · 5Y

$10,000 · 5Y$12,184XBI

Lowest cost0.35%XBI · $35 on $10k

Most income0.46%TMED · $46 on $10k

Smallest drop−11.1%TMED · worst fall in 1Y

Held in common16.4%TMED and XBI

TMED

XBI

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF · $35MState Street SPDR S&P Biotech ETF · $10.3B

[…]3 years · per year[…] · $23,131+32.3%

[…]5 years · per year[…] · $12,184+4.0%

0.44%Expense ratio$44 · $35 on $10k · lower wins0.35%

0.46%12-mo yield$46 · $35 on $10k0.35%

−11.1%Worst dropSmaller wins−14.9%

19.6%VolatilityLower wins30.1%

3–1TMED wins

$10,000 · 5 yearsOne scale

Shared top holdingsTMED · XBI

1.4%BIIB1.8%

2.2%PCVX1.3%

1.9%CYTK1.1%

1.0%ORKA1.7%

Held in common16.4%

End-of-day Nov 9, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

Both

5Y2 funds

#			Trend
1	BXBI	State Street SPDR S&P Biotech ETFRead Desk		0.35%	0.35%	+3.1%	+28.8%	+44.2%	+32.3%	+4.0%	−14.9%	$10.3B
2	ATMED	T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFRead Desk		0.44%	0.46%	+2.8%	+18.4%	+24.8%	new	new	−11.1%	$35M

End-of-day Nov 9, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Both

5Y2 funds

#			Trend
1	BXBI	State Street SPDR S&P Biotech ETFRead Desk		0.35%	0.35%	+3.1%	+28.8%	+44.2%	+32.3%	+4.0%	−14.9%	$10.3B
2	ATMED	T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFRead Desk		0.44%	0.46%	+2.8%	+18.4%	+24.8%	new	new	−11.1%	$35M

End-of-day Nov 9, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

TMED vs XBI

TMED

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care

[…]

XBI

SPDR S&P Biotech

$12,184

MeasureTMEDXBI

Fee0.44%0.35%

Cost on $10k a year$44$35

Yield0.46%0.35%

5 years, per year[…]+4.0%

3 years, per year[…]+32.3%

Worst drop · 1Y−11.1%−14.9%

Volatility · 1Y19.6%30.1%

3–1measures won
TMED first

16.4%

holdings shared

Nov 9, 2026 · $10,000 five years ago, dividends reinvested

SCHD vs VIG

YTD

SchwabSCHD

+33.2%

VIGVanguard

+14.8%

+33.2%Year to date+14.8%

3.0%Yield1.5%

$122BAssets$109B

2–0SCHD wins

End-of-day Nov 9, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+6.6%

JEPIJ.P. Morgan

+7.5%

+6.6%Year to date+7.5%

12.4%Yield7.9%

$40.7BAssets$45.2B

1–1level

End-of-day Nov 9, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.3%

SPYSPDR

+11.2%

+11.3%Year to date+11.2%

1.0%Yield1.0%

$179BAssets$778B

1–0SPYM wins

End-of-day Nov 9, 2026

Overlap: TMED, XBI

Today

16.4%most shared, TMED and XBI

TMEDXBI

TMED—16.4%

XBI16.4%—

End-of-day Nov 9, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$2most kept, TMED

TMED$46 − $44 = $2

XBI$35 − $35 = −$0

KeptFee

End-of-day Nov 9, 2026 · yield in dollars minus the fee